OR WAIT null SECS
Advances in automation and cleanroom technology improve efficiency for small commercial quantities of aseptically filled drug products.
With the increase in drug products targeted to specific patient groups, including orphan drugs and even individualized medicine, manufacturers must consider how to optimize the manufacturing process for aseptic fill/finish of drugs in small batch sizes. Pharmaceutical Technology spoke with Joerg Zimmermann, vice-president of Development Service and External Affairs at Vetter, about these challenges and the equipment and facility options to consider.
Jennifer Markarian is manufacturing editor of Pharmaceutical Technology.
eBook: Biologics and Sterile Drug Manufacturing, May 2021
When referring to this article, please cite it as J. Markarian, “Filling Small Batches" Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2021).